Zydus Recalls 14,800 Bottles Of Bromocriptine Mesylate Capsules

New Delhi: Zydus Cadila is recalling over 14,800 bottles of Bromocriptine Mesylate capsules manufactured by Cadila Healthcare on account of out of specification results. According to information available on the US Food and Drug Administration (FDA) site, Zydus  Pharmaceuticals USA Inc is recalling drugs manufactured by Ahmedabad-based Cadila Healthcare. 14,808 bottles of Bromocriptine Mesylate Capsules USP, 5 mg are being recalled...